 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 July 1998 | Volume 129 Issue 2 | Pages 144-158
Purpose: To review information on the benefits of screening with a sensitive thyroid-stimulating hormone (TSH) test for thyroid dysfunction in asymptomatic patients seeking primary care for other reasons. This paper focuses on whether screening should be aimed at detection of subclinical thyroid dysfunction and whether persons with mildly abnormal TSH levels can benefit.
Data Sources: A MEDLINE search for studies of screening for thyroid dysfunction and of treatment for complications of subclinical thyroid dysfunction.
Study Selection: Studies of screening with thyroid function tests in the general adult population or in patients seen in the general office setting were selected (n = 33). All controlled studies of treatment in patients with subclinical hypothyroidism or subclinical hyperthyroidism were also included (n = 23).
Data Extraction: The prevalence of overt and subclinical thyroid dysfunction, the evidence for the efficacy of treatment, and the incidence of complications in defined age and sex groups were extracted from each study.
Data Synthesis: Screening can detect symptomatic but unsuspected overt thyroid dysfunction. The yield is highest for women older than 50 years of age: In this group, 1 in 71 women screened could benefit from relief of symptoms. Evidence of the efficacy of treatment for subclinical thyroid dysfunction is inconclusive.
Conclusions: Even though treatment for subclinical thyroid dysfunction is controversial, office-based screening to detect overt thyroid dysfunction may be indicated in women older than 50 years of age. Large randomized trials are needed to determine the likelihood that treatment will improve quality of life in otherwise healthy patients who have mildly elevated TSH levels.
Author and Article Information
From Portland Veterans Affairs Medical Center and Providence Portland Medical Center, Portland, Oregon.
POSITION PAPER
Screening for Thyroid Disease: An Update
Acknowledgments: The authors thank Dan Kent, MD, Harold Sox, MD, and other reviewers for their comments.
Grant Support: Dr. Helfand was a Robert Wood Johnson Generalist Faculty Scholar when this work was done.
Requests for Reprints: Mark Helfand, MD, MPH, Department of Medicine (111-P), Portland Veterans Affairs Medical Center, Box 1034, Portland, OR 97201.
Current Author Addresses: Dr. Helfand: Department of Medicine (111-P), Portland Veterans Affairs Medical Center, Box 1034, Portland, OR 97201.
This article has been cited by other articles:
|
|
 |
|
  P. W. Ladenson Cardiovascular Consequences of Subclinical Thyroid Dysfunction: More Smoke but No Fire Ann Intern Med, June 3, 2008; 148(11): 880 - 881. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Biondi and D. S. Cooper The Clinical Significance of Subclinical Thyroid Dysfunction Endocr. Rev., February 1, 2008; 29(1): 76 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Hal Scofield, G. R Bruner, J. B Harley, and B. Namjou Autoimmune thyroid disease is associated with a diagnosis of secondary Sjogren's syndrome in familial systemic lupus Ann Rheum Dis, March 1, 2007; 66(3): 410 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wilson, J. V. Parle, L. M. Roberts, A. K. Roalfe, F. D. R. Hobbs, P. Clark, M. C. Sheppard, M. D. Gammage, H. M. Pattison, J. A. Franklyn, et al. Prevalence of Subclinical Thyroid Dysfunction and Its Relation to Socioeconomic Deprivation in the Elderly: A Community-Based Cross-Sectional Survey J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4809 - 4816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zoncu, F. Pigliaru, C. Putzu, L. Pisano, S. Vargiu, M. Deidda, S. Mariotti, and G. Mercuro Cardiac function in borderline hypothyroidism: a study by pulsed wave tissue Doppler imaging Eur. J. Endocrinol., April 1, 2005; 152(4): 527 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Hueston and W. S. Pearson Subclinical Hypothyroidism and the Risk of Hypercholesterolemia Ann. Fam. Med, July 1, 2004; 2(4): 351 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E H Hoogendoorn, M den Heijer, A P J van Dijk, and A R Hermus Subclinical hyperthyroidism: to treat or not to treat? Postgrad. Med. J., July 1, 2004; 80(945): 394 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Helfand Screening for Subclinical Thyroid Dysfunction in Nonpregnant Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, January 20, 2004; 140(2): 128 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Ganotakis, K. Mandalaki, M. Tampakaki, N. Malliaraki, E. Mandalakis, G. Vrentzos, J. Melissas, and E. Castanas Subclinical Hypothyroidism and Lipid Abnormalities in Older Women Attending a Vascular Disease Prevention Clinic: Effect of Thyroid Replacement Therapy Angiology, September 1, 2003; 54(5): 569 - 576. [Abstract] [PDF]
|
|
|
|
 |
|
 G. D. Schiff, D. Klass, J. Peterson, G. Shah, and D. W. Bates Linking Laboratory and Pharmacy: Opportunities for Reducing Errors and Improving Care Arch Intern Med, April 28, 2003; 163(8): 893 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Sgarbi, F. G. Villaca, B. Garbeline, H. E. Villar, and J. H. Romaldini The Effects of Early Antithyroid Therapy for Endogenous Subclinical Hyperthyroidism in Clinical and Heart Abnormalities J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1672 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Umpierrez, K. A. Latif, M. B. Murphy, H. C. Lambeth, F. Stentz, A. Bush, and A. E. Kitabchi Thyroid Dysfunction in Patients With Type 1 Diabetes: A longitudinal study Diabetes Care, April 1, 2003; 26(4): 1181 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Biondi, E. A. Palmieri, G. Lombardi, and S. Fazio Effects of Subclinical Thyroid Dysfunction on the Heart Ann Intern Med, December 3, 2002; 137(11): 904 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Huber, J.-J. Staub, C. Meier, C. Mitrache, M. Guglielmetti, P. Huber, and L. E. Braverman Prospective Study of the Spontaneous Course of Subclinical Hypothyroidism: Prognostic Value of Thyrotropin, Thyroid Reserve, and Thyroid Antibodies J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3221 - 3226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Edelman, M. K. Olsen, T. K. Dudley, A. C. Harris, and E. Z. Oddone Impact of Diabetes Screening on Quality of Life Diabetes Care, June 1, 2002; 25(6): 1022 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kroenke A 75-Year-Old Man With Depression JAMA, March 27, 2002; 287(12): 1568 - 1576. [Full Text] [PDF]
|
|
|
|
|
|
J. G. Hollowell, N. W. Staehling, W. D. Flanders, W. H. Hannon, E. W. Gunter, C. A. Spencer, and L. E. Braverman Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 489 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Durelli, B. Ferrero, A. Oggero, E. Verdun, A. Ghezzi, E. Montanari, and M. Zaffaroni Liver and thyroid function and autoimmunity during interferon-{beta}1b treatment for MS Neurology, October 23, 2001; 57(8): 1363 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Muller, H. A. Drexhage, and A. Berghout Postpartum Thyroiditis and Autoimmune Thyroiditis in Women of Childbearing Age: Recent Insights and Consequences for Antenatal and Postnatal Care Endocr. Rev., October 1, 2001; 22(5): 605 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Meier, J.-J. Staub, C.-B. Roth, M. Guglielmetti, M. Kunz, A. R. Miserez, J. Drewe, P. Huber, R. Herzog, and B. Muller TSH-Controlled L-Thyroxine Therapy Reduces Cholesterol Levels and Clinical Symptoms in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Trial (Basel Thyroid Study) J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4860 - 4866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Toft Subclinical Hyperthyroidism N. Engl. J. Med., August 16, 2001; 345(7): 512 - 516. [Full Text] [PDF]
|
|
|
|
|
|
D. S. Cooper Subclinical Hypothyroidism N. Engl. J. Med., July 26, 2001; 345(4): 260 - 265. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Negro, D. Dazzi, and A. Pezzarossa The management of thyroid disease by GPs Fam. Pract., April 1, 2001; 18(2): 195 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Miller Domain-constrained Generation of Clinical Condition Sets to Help Test Computer-based Clinical Guidelines J. Am. Med. Inform. Assoc., March 1, 2001; 8(2): 131 - 145. [Abstract] [Full Text]
|
|
|
|
|
|
B. Biondi, E. A. Palmieri, S. Fazio, C. Cosco, M. Nocera, L. Saccà, S. Filetti, G. Lombardi, and F. Perticone Endogenous Subclinical Hyperthyroidism Affects Quality of Life and Cardiac Morphology and Function in Young and Middle-Aged Patients J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4701 - 4705. [Abstract] [Full Text]
|
|
|
|
|
|
M. D. Danese, P. W. Ladenson, C. L. Meinert, and N. R. Powe Effect of Thyroxine Therapy on Serum Lipoproteins in Patients with Mild Thyroid Failure: A Quantitative Review of the Literature J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 2993 - 3001. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. M. Kaplan Clinical Perspectives in the Diagnosis of Thyroid Disease Clin. Chem., August 1, 1999; 45(8): 1377 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Crapo The Time Is Not Ripe To Screen J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1816 - 1819. [Full Text]
|
|
|
|
|
|
B. Biondi, S. Fazio, E. A. Palmieri, C. Carella, N. Panza, A. Cittadini, F. Bonè, G. Lombardi, and L. Saccà Left Ventricular Diastolic Dysfunction in Patients with Subclinical Hypothyroidism J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2064 - 2067. [Abstract] [Full Text]
|
|
Article
